BeiGene vs EyeGate Pharmaceuticals
BeiGene vs EyeGate Pharmaceuticals, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BeiGene is on 64/100 and EyeGate Pharmaceuticals on 32/100.
Where each one leads
BeiGene
- our overall score: 64/100 against 32/100
- agent readiness: 50/100 against 39/100
- domain rating: 68/100 against 34/100
- funding raised: $358M against $45.5M
EyeGate Pharmaceuticals
Leads on none of the measures we hold for both companies.
At a glance
| Measure | BeiGene | EyeGate Pharmaceuticals |
|---|---|---|
| What it is | A global oncology company developing and commercializing innovative cancer treatments. | Clinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B | B2C | B2B2C | B2G |
| Offering | Platform | Software | hardware | services | marketplace | platform |
| Founded | 2010 | 2000 |
| Headquarters | Cambridge, United States | Waltham, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BeiGene | EyeGate Pharmaceuticals |
|---|---|---|
| Open roles | 100 | Not published |
| Total funding | $358M | $45.5M |
| Latest round | Secondary Offering | Debt |
| Valuation | $15B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BeiGene | EyeGate Pharmaceuticals |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 32/100 |
| Traction | 40/100 | 38/100 |
| Team | 30/100 | 30/100 |
| Search visibility | 17/100 | 5/100 |
| Quality | 88/100 | 35/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 68/100 | 34/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BeiGene | EyeGate Pharmaceuticals |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
| Analytics | Not detected | Google Analytics 4, Google Tag Manager |
BeiGene vs EyeGate Pharmaceuticals: common questions
Which is better, BeiGene or EyeGate Pharmaceuticals?
On our 0-100 score BeiGene rates higher (64/100 against 32/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do BeiGene and EyeGate Pharmaceuticals compare on the numbers?
BeiGene leads on our overall score (64/100 against 32/100), agent readiness (50/100 against 39/100), domain rating (68/100 against 34/100), funding raised ($358M against $45.5M).
Read the full BeiGene review and pricing or the EyeGate Pharmaceuticals review and pricing. You can also browse other BeiGene alternatives we track.